Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 Into Spain

PR Newswire03:30 ET

Emerald to Participate in December Investor Conferences

BusinesswireNov 18 08:30 ET

Aga Khan Emerald Fetches Record $9 Mn In Geneva Auction

IBTimesNov 12 22:42 ET

Emerald Bay Risk Solutions Launches Inaugural Casualty Program With Vanderbilt

BusinesswireNov 12 08:30 ET

Resolution Therapeutics Announces New Clinical and Preclinical Data Showcasing Regenerative Macrophage Therapy at AASLD The Liver Meeting 2024 to Support the Ongoing Phase 1/2 Study for RTX001 in End-Stage Liver Disease

PR NewswireNov 11 03:30 ET

Emerald Resources NL's (ASX:EMR) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Yahoo FinanceNov 4 16:38 ET